2 Harbour Square
Malin Corporation plc, through its subsidiaries, operates as a life sciences company primarily in Ireland. The company develops, manufactures, and markets injectable medications, including pain, anti-infective, and other medications available in premix bags, liquid and lyophilized vials, and ampoules forms for the hospital and other provider segments. It also develops Emba embolisation device used in the neurovascular field, as well as engages in licensing, registering, and commercializing approved therapeutics to address unmet medical needs. Malin Corporation plc was incorporated in 2014 and is based in Dún Laoghaire, Ireland.
CEO: Mr. Kelly Martin
CFO: Mr. Darragh Lyons
Chairman: John Given
Chief Investment Officer: Dr. Adrian Howd Ph.D.